MeSH Review:
Arrhythmia
- Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. Echt, D.S., Liebson, P.R., Mitchell, L.B., Peters, R.W., Obias-Manno, D., Barker, A.H., Arensberg, D., Baker, A., Friedman, L., Greene, H.L. N. Engl. J. Med. (1991)
- A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators. Cohn, J.N., Goldstein, S.O., Greenberg, B.H., Lorell, B.H., Bourge, R.C., Jaski, B.E., Gottlieb, S.O., McGrew, F., DeMets, D.L., White, B.G. N. Engl. J. Med. (1998)
- FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Wehrens, X.H., Lehnart, S.E., Huang, F., Vest, J.A., Reiken, S.R., Mohler, P.J., Sun, J., Guatimosim, S., Song, L.S., Rosemblit, N., D'Armiento, J.M., Napolitano, C., Memmi, M., Priori, S.G., Lederer, W.J., Marks, A.R. Cell (2003)
- Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. Heger, J.J., Prystowsky, E.N., Jackman, W.M., Naccarelli, G.V., Warfel, K.A., Rinkenberger, R.L., Zipes, D.P. N. Engl. J. Med. (1981)
- A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Curran, M.E., Splawski, I., Timothy, K.W., Vincent, G.M., Green, E.D., Keating, M.T. Cell (1995)
- Familial polymorphic ventricular arrhythmias: a quarter century of successful medical treatment based on serial exercise-pharmacologic testing. Fisher, J.D., Krikler, D., Hallidie-Smith, K.A. J. Am. Coll. Cardiol. (1999)
- Sleep-induced apnea syndrome. Prevalence of cardiac arrhythmias and their reversal after tracheostomy. Tilkian, A.G., Guilleminault, C., Schroeder, J.S., Lehrman, K.L., Simmons, F.B., Dement, W.C. Am. J. Med. (1977)
- The significance of the interictal spike discharge: a review. Hughes, J.R. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. (1989)
- Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form. Verloes, A., Massin, M., Lombet, J., Grattagliano, B., Soyeur, D., Rigo, J., Koulischer, L., Van Hoof, F. Am. J. Med. Genet. (1997)
- The effect of esmolol on ST-segment depression and arrhythmias after electroconvulsive therapy. Zvara, D.A., Brooker, R.F., McCall, W.V., Foreman, A.S., Hewitt, C., Murphy, B.A., Royster, R.L. Convulsive therapy. (1997)
- Adenosine 5'-triphosphate: a P2-purinergic agonist in the myocardium. Vassort, G. Physiol. Rev. (2001)
- The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient. Costantini, D.L., Arruda, E.P., Agarwal, P., Kim, K.H., Zhu, Y., Zhu, W., Lebel, M., Cheng, C.W., Park, C.Y., Pierce, S.A., Guerchicoff, A., Pollevick, G.D., Chan, T.Y., Kabir, M.G., Cheng, S.H., Husain, M., Antzelevitch, C., Srivastava, D., Gross, G.J., Hui, C.C., Backx, P.H., Bruneau, B.G. Cell (2005)
- Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. Lehnart, S.E., Wehrens, X.H., Reiken, S., Warrier, S., Belevych, A.E., Harvey, R.D., Richter, W., Jin, S.L., Conti, M., Marks, A.R. Cell (2005)
- Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases. Smith, T.W., Butler, V.P., Haber, E., Fozzard, H., Marcus, F.I., Bremner, W.F., Schulman, I.C., Phillips, A. N. Engl. J. Med. (1982)
- Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm. Myerburg, R.J., Kessler, K.M., Mallon, S.M., Cox, M.M., deMarchena, E., Interian, A., Castellanos, A. N. Engl. J. Med. (1992)
- Oral flecainide acetate for the treatment of ventricular arrhythmias. Anderson, J.L., Stewart, J.R., Perry, B.A., Van Hamersveld, D.D., Johnson, T.A., Conard, G.J., Chang, S.F., Kvam, D.C., Pitt, B. N. Engl. J. Med. (1981)
- A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. Mason, J.W. N. Engl. J. Med. (1993)
- Cardiac arrhythmias associated with disopyramide. Kinney, E.L., Field, E.H., Salmon, M.P., Zelis, R. N. Engl. J. Med. (1980)
- Effect of theophylline on sleep-disordered breathing in heart failure. Javaheri, S., Parker, T.J., Wexler, L., Liming, J.D., Lindower, P., Roselle, G.A. N. Engl. J. Med. (1996)
- Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). Tristani-Firouzi, M., Jensen, J.L., Donaldson, M.R., Sansone, V., Meola, G., Hahn, A., Bendahhou, S., Kwiecinski, H., Fidzianska, A., Plaster, N., Fu, Y.H., Ptacek, L.J., Tawil, R. J. Clin. Invest. (2002)
- TRPC1 forms the stretch-activated cation channel in vertebrate cells. Maroto, R., Raso, A., Wood, T.G., Kurosky, A., Martinac, B., Hamill, O.P. Nat. Cell Biol. (2005)
- A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. Viswanathan, P.C., Benson, D.W., Balser, J.R. J. Clin. Invest. (2003)
- Normal and abnormal consequences of apoptosis in the human heart. James, T.N. Annu. Rev. Physiol. (1998)
- Tyrosine administration decreases vulnerability to ventricular fibrillation in the normal canine heart. Scott, N.A., DeSilva, R.A., Lown, B., Wurtman, R.J. Science (1981)
- Contraindicated use of cisapride: impact of food and drug administration regulatory action. Smalley, W., Shatin, D., Wysowski, D.K., Gurwitz, J., Andrade, S.E., Goodman, M., Chan, K.A., Platt, R., Schech, S.D., Ray, W.A. JAMA (2000)
- Ventricular arrhythmias in chronic stable angina pectoris with surgical or medical treatment. de Soyza, N., Murphy, M.L., Bissett, J.K., Kane, J.J., Doherty, J.E. Ann. Intern. Med. (1978)
- Dromotropic effects of adenosine and adenosine antagonists in the treatment of cardiac arrhythmias involving the atrioventricular node. Berne, R.M., DiMarco, J.P., Belardinelli, L. Circulation (1984)
- MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Abbott, G.W., Sesti, F., Splawski, I., Buck, M.E., Lehmann, M.H., Timothy, K.W., Keating, M.T., Goldstein, S.A. Cell (1999)
- SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Wang, Q., Shen, J., Splawski, I., Atkinson, D., Li, Z., Robinson, J.L., Moss, A.J., Towbin, J.A., Keating, M.T. Cell (1995)
- KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Kubisch, C., Schroeder, B.C., Friedrich, T., Lütjohann, B., El-Amraoui, A., Marlin, S., Petit, C., Jentsch, T.J. Cell (1999)
- KCNE2 confers background current characteristics to the cardiac KCNQ1 potassium channel. Tinel, N., Diochot, S., Borsotto, M., Lazdunski, M., Barhanin, J. EMBO J. (2000)
- A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. Steinbeck, G., Andresen, D., Bach, P., Haberl, R., Oeff, M., Hoffmann, E., von Leitner, E.R. N. Engl. J. Med. (1992)
- Preoperative propranolol therapy and aortocoronary bypass operation. Slogoff, S., Keats, A.S., Ott, E. JAMA (1978)
- Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists? Stevenson, W.G., Ridker, P.M. JAMA (1996)
- Suppression of ventricular arrhythmias during ischemia-reperfusion by agents inhibiting Ins(1,4,5)P3 release. Du, X.J., Anderson, K.E., Jacobsen, A., Woodcock, E.A., Dart, A.M. Circulation (1995)
- Abnormal signal-averaged electrocardiograms in patients with nonischemic congestive cardiomyopathy: relationship to sustained ventricular tachyarrhythmias. Poll, D.S., Marchlinski, F.E., Falcone, R.A., Josephson, M.E., Simson, M.B. Circulation (1985)